trial · primary record
Lasofoxifene in combination with abemaciclib
Metastatic Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2028-04 |
| Primary endpoint | Progression free survival (PFS) |
| Registry ID | NCT05696626 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:22.992Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05696626
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.